{"id":"CHEMBL1092581","canonicalSmiles":"CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12","inchiKey":"WTDWVLJJJOTABN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NESBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HCV 796","HCV-796","Nesbuvir"],"crossReferences":{"drugbank":["DB07238"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL113194","canonicalSmiles":"CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)ncnc21","inchiKey":"PPFZLLAIQRZNJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113194","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160714","canonicalSmiles":"CC(C)NC[C@H](O)COc1ccc(O)cc1","inchiKey":"ADUKCCWBEDSMEB-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRENALTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenol metabolite","Prenalterol"],"crossReferences":{"Wikipedia":["Prenalterol"],"drugbank":["DB13777"],"chEBI":["8391"]},"childChemblIds":["CHEMBL3085478"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL119709","canonicalSmiles":"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"HUJXGQILHAUCCV-MOROJQBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IB-MECA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IB-MECA"],"crossReferences":{"PubChem":["26752055","26752056","56463617","90341246"],"drugbank":["DB05511"],"chEBI":["73286"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198191","canonicalSmiles":"CCCC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"RYAZZWWVNUWKNB-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198191","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06929"]},"childChemblIds":["CHEMBL3423003","CHEMBL598213"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1199324","canonicalSmiles":"C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"BARDROPHSZEBKC-OITMNORJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAPREPITANT","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ivemend"],"synonyms":["Fosaprepitant","L-758298"],"crossReferences":{"DailyMed":["fosaprepitant%20dimeglumine"],"Wikipedia":["Fosaprepitant"],"drugbank":["DB06717"],"chEBI":["64321"]},"childChemblIds":["CHEMBL1201782","CHEMBL1159797"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006911","MONDO_0021148","MONDO_0008170","HP_0002017","EFO_0004888","EFO_0001378","EFO_0004252","MONDO_0043510","EFO_0000691","EFO_0000311","MONDO_0002715"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL1200424","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Zn+2]","inchiKey":"HVASDHJNLYRZEA-UHFFFAOYSA-I","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTETATE ZINC TRISODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL780","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pentetate zinc trisodium"],"synonyms":["Kelazin","Pentetate Zinc Trisodium","Pentetate zinc trisodium","Trisodium zinc dtpa","Zinc trisodium pentetate","Zinc-dtpa"],"crossReferences":{"DailyMed":["pentetate%20zinc%20trisodium"],"DrugCentral":["4754"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200431","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOPENTETATE DIMEGLUMINE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnevist"],"synonyms":["Dimeglumine gadopentetate","Gadopentate dimeglumine","Gadopentetate dimeglumine","Gadopentetic acid","Gadopentetic acid dimeglumine salt","Meglumine gadopentetate","SH L 451 A","SH-L 451 A","SH-L-451-A","SHL-451A"],"crossReferences":{"DailyMed":["gadopentetate%20dimeglumine"],"DrugCentral":["4558"],"Wikipedia":["Gadopentetic_acid"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200791","canonicalSmiles":"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl","inchiKey":"BEEDODBODQVSIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYMETAZOLINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL762","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrazine","Ocuclear","Rhofade","Upneeq","Visine","Visine l.r."],"synonyms":["Agn-199201","NSC-757254","Oximetazoline hydrochloride","Oxymetazoline hcl","Oxymetazoline hydrochloride","SCH 9384","SCH-9384"],"crossReferences":{"DailyMed":["oxymetazoline%20hydrochloride"],"PubChem":["26747607","26747608","50106757","50106758","50106759","856146"],"chEBI":["7863"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MONDO_0001330","Orphanet_98578","EFO_1000760","EFO_0005854","EFO_0009540","EFO_0007486","HP_0010783","EFO_1000906","EFO_0007141","HP_0001742","EFO_0007214","EFO_0003956","MONDO_0000728"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 7 approved and 3 investigational indications."}
{"id":"CHEMBL1200965","canonicalSmiles":"CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C.Cl","inchiKey":"IWVTXAGTHUECPN-ANBBSHPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BACAMPICILLIN HYDROCHLORIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1583","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambaxin","Spectrobid"],"synonyms":["Bacampicillin hcl","Bacampicillin hydrochloride","Becampicillin hydrochloride","NSC-758228"],"crossReferences":{"PubChem":["144204191","170465170","56463038"],"chEBI":["2969"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and has 1 investigational indication."}
{"id":"CHEMBL1201120","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.Cl","inchiKey":"WFBMIPUMYUHANP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"REMIFENTANIL HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1005","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultiva"],"synonyms":["GI 87084B","GI-87084B","Remifentanil hcl","Remifentanil hydrochloride"],"crossReferences":{"DailyMed":["remifentanil%20hydrochloride"],"chEBI":["32091"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005251"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201206","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1","inchiKey":"OWWLUIWOFHMHOQ-XGHATYIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPECURONIUM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pipecuronium"],"crossReferences":{"drugbank":["DB01338"],"chEBI":["8230"]},"childChemblIds":["CHEMBL1200722"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1201538","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN LISPRO","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Admelog","Admelog solostar","Humalog","Humalog kwikpen","Humalog pen","Humalog tempo pen","Ins humalog"],"synonyms":["Insulin Lispro Recombinant","Insulin lispro","Insulin lispro recombinant"],"crossReferences":{"DailyMed":["insulin%20lispro","insulin%20lispro%20recombinant","insulin%20lispro-aabc"],"DrugCentral":["5002"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0004593","MONDO_0005147","HP_0003074","EFO_0000401","EFO_0001645","MONDO_0005148","EFO_0000400"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for diabetes mellitus and has 3 investigational indications."}
{"id":"CHEMBL1231723","canonicalSmiles":"CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","inchiKey":"ONJQDTZCDSESIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIDOCANOL","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asclera","Varithena"],"synonyms":["Polidocanol","Polyoxyl 9 lauryl ether"],"crossReferences":{"DailyMed":["polidocanol"],"DrugCentral":["4614"],"PubChem":["144205947","170466791","29218048","50111750"],"drugbank":["DB06811"],"chEBI":["46859"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for varicose veins and telangiectasis and has 4 investigational indications."}
{"id":"CHEMBL1234363","canonicalSmiles":"OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"FYGDTMLNYKFZSV-PXXRMHSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALTOTRIOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206953"],"drugbank":["DB03277"],"chEBI":["27931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235490","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@@H](O)C2","inchiKey":"CYHOMWAPJJPNMW-RNLVFQAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOTROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rel-Tropine"],"crossReferences":{"drugbank":["DB04026"],"chEBI":["15742"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255800","canonicalSmiles":"CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\\C=C\\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C","inchiKey":"ZVGNESXIJDCBKN-UUEYKCAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIDAXOMICIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dificid","Dificlir"],"synonyms":["Fidaxomicin","OPT-80","PAR-101"],"crossReferences":{"DailyMed":["fidaxomicin"],"Wikipedia":["Fidaxomicin"],"drugbank":["DB08874"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for infection and diarrhea and has 2 investigational indications."}
{"id":"CHEMBL1257096","canonicalSmiles":"COc1c(N2CCC/C(=C(\\F)CN)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"VMKVDAAFMQKZJS-LFIBNONCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVAROFLOXACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acorafloxacin","Avarofloxacin","JNJ-32729463-AAA","JNJ-Q2"],"childChemblIds":["CHEMBL2364603"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1266","canonicalSmiles":"c1ccc2c(c1)CCCC2C1=NCCN1","inchiKey":"BYJAVTDNIXVSPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROZOLINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Caltheon","Tetrahydrozoline","Tetryzoline","Tyzine"],"crossReferences":{"PubChem":["90341828"],"Wikipedia":["Tetrahydrozoline"],"drugbank":["DB06764"],"chEBI":["28674"]},"childChemblIds":["CHEMBL1200413"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MP_0001845","EFO_0000678","EFO_1000906","EFO_0005751","HP_0001742"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for nasal congestion and eye allergy and has 3 investigational indications."}
{"id":"CHEMBL1386","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANSPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cisplatin","Platinol","Platinol-Aq"],"synonyms":["NSC-131558","Trans-ddp","Trans-diaminedichloroplatinum","Trans-diamminedichloroplatinum","Transplatin"],"crossReferences":{"PubChem":["124891673","26748616"],"chEBI":["27899"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL146095","canonicalSmiles":"O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12","inchiKey":"GWOFUCIGLDBNKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLAFENINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," France"],"classes":["Immune system toxicity"],"year":1984},"tradeNames":[],"synonyms":["Glafenin","Glafenine","Glaphenine","Glycerylaminophenaquine","NSC-757808","R 1707","R-1707"],"crossReferences":{"PubChem":["26748455"],"chEBI":["31653"]},"childChemblIds":["CHEMBL1572751"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0001945","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever. It was withdrawn in Germany and  France initially in 1984 due to Immune system toxicity."}
{"id":"CHEMBL1643880","canonicalSmiles":"O=C(N[C@H]1CN2CCC1CC2)c1c[nH]c2ccsc2c1=O","inchiKey":"AFUWQWYPPZFWCO-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUMOSETRAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DDP733","Pumosetrag"],"crossReferences":{"drugbank":["DB12402"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1651026","canonicalSmiles":"CC(C)C[C@H](NC(=O)CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCS(C)(=O)=O)C(N)=O","inchiKey":"OUPXSLGGCPUZJJ-SARDKLJWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL1651026","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05875"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1673148","canonicalSmiles":"C[N+](C)(CCOc1ccccc1)Cc1ccccc1.O=C([O-])c1cc2ccccc2cc1O","inchiKey":"PMPQCPQAHTXCDK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPHENIUM HYDROXYNAPHTHOATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alcopar"],"synonyms":["Alcopara","Befen","Befeniol","Bephenamine hydroxynaphthoate","Bephene oxinaphtoate","Bephenii hydroxynaphthoas","Bephenium 3-hydroxy-2-naphthoate","Bephenium embonate","Bephenium hydroxynaphthoate","Debefenium","Fedal-uncin","Frantin","Lecibis","NSC-759245","Naftamon","Naphtamon","Naphtamone","Nemex"],"crossReferences":{"Wikipedia":["Bephenium_hydroxynaphthoate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1697830","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"VUHJZBBCZGVNDZ-TTYLFXKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMADINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlormadinone"],"crossReferences":{"PubChem":["144206541"],"TG-GATEs":["126"],"drugbank":["DB13528"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1736","canonicalSmiles":"CC(=O)Nc1c(I)c(C(=O)O)c(I)c(N(C)C(C)=O)c1I","inchiKey":"GGGDNPWHMNJRFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRIZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metrizoate","Metrizoic acid","V08AA02"],"crossReferences":{"PubChem":["50125803"],"Wikipedia":["Metrizoic_acid"],"drugbank":["DB09346"],"chEBI":["34847"]},"childChemblIds":["CHEMBL2364738","CHEMBL1200353","CHEMBL1200423","CHEMBL2068723"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1743067","drugType":"Antibody","blackBoxWarning":false,"name":"SAMALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALXN-6000","ALXN6000","Samalizumab"],"linkedTargets":{"rows":["ENSG00000091972"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","EFO_0000222","EFO_0001378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1780010","canonicalSmiles":"COc1cc2c(cc1OCCC[18F])CCN1C[C@@H](CC(C)C)[C@H](O)C[C@H]21","inchiKey":"GNKGXQHHUUEYQV-WTHAECTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBENAZINE F 18","maximumClinicalTrialPhase":2,"parentId":"CHEMBL579217","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(18F)AV 133","(18F)AV-133","18F-AV-133","18f-dtbz","AV-133 F-18","Dtbz f-18","Florbenazine (18f)","Florbenazine f 18","Florbenazine f-18","Florbenazine, f-18"],"crossReferences":{"drugbank":["DB14945"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1900528","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"LERNTVKEWCAPOY-DZZGSBJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOTROPIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Braltus","Spiriva","Spiriva respimat"],"synonyms":["Tiotropium","Tiotropium cation","Tiotropium ion"],"crossReferences":{"DailyMed":["tiotropium%20bromide"],"PubChem":["50113015"],"drugbank":["DB01409"]},"childChemblIds":["CHEMBL4440620","CHEMBL3545181"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","HP_0000083","HP_0006536","EFO_0000464","EFO_0006505","EFO_1001919","MONDO_0004979","Orphanet_586","EFO_0000341","HP_0025428","MONDO_0004784"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 6 approved and 5 investigational indications."}
{"id":"CHEMBL204593","canonicalSmiles":"Cc1cc(S(=O)(=O)N[C@@H](C(=O)NO)C2CCOCC2)ccc1F","inchiKey":"LUCFRFDOOYLALP-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2063869","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1","inchiKey":"WZRFLSDVFPIXOV-LRQRDZAKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GDC-0152","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gdc-0152"],"crossReferences":{"drugbank":["DB12380"]},"childChemblIds":["CHEMBL2063872","CHEMBL2063871"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2103799","canonicalSmiles":"CC[C@H](C)CC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1","inchiKey":"SDDSJMXGJNWMJY-BRHAQHMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBIPROSTONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobiprostone","RU-8811","SPI-8811"],"crossReferences":{"drugbank":["DB05514"]},"linkedTargets":{"rows":["ENSG00000114859"],"count":1},"linkedDiseases":{"rows":["EFO_0004607","EFO_0000666","EFO_1001904"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103847","canonicalSmiles":"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO","inchiKey":"FWFGIHPGRQZWIW-SQNIBIBYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOSEDOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHR 2797","CHR-2797","Tosedostat"],"crossReferences":{"drugbank":["DB11781"]},"linkedTargets":{"rows":["ENSG00000002549","ENSG00000172901","ENSG00000196236","ENSG00000164307","ENSG00000215440","ENSG00000138792","ENSG00000141279","ENSG00000176393","ENSG00000111142","ENSG00000164308","ENSG00000166825","ENSG00000123992","ENSG00000142327","ENSG00000113441","ENSG00000108039","ENSG00000172878","ENSG00000148120","ENSG00000164024","ENSG00000122121"],"count":19},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002618","EFO_0000616","EFO_0000222","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2103858","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)C[C@@H]1OC","inchiKey":"VGDDOIZXGFJDRC-VJTSUQJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARONAPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-7505","Naronapride"],"crossReferences":{"drugbank":["DB05542"]},"childChemblIds":["CHEMBL2105706"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["HP_0012450"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2103901","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O","inchiKey":"QSIRXSYRKZHJHX-TWXHAJHVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SINAPULTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI 01","ATI-01","Kl4 peptide","PEPTIDE KL-4","PEPTIDE KL4","RWJ-45652","Sinapultide"],"crossReferences":{"drugbank":["DB11332"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104578","canonicalSmiles":"O=C(O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O","inchiKey":"UVAUYSRYXACKSC-ULQDDVLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILAZAPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilazapril diacid","Cilazaprilat","Cilazaprilat anhydrous","RO 31-3113","RO-31-3113","RO-313113"],"crossReferences":{"drugbank":["DB15565"],"chEBI":["81005"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104627","canonicalSmiles":"O=[N+]([O-])c1ccc(/C=C/c2cccc(CO)n2)o1","inchiKey":"JQKHJQJVKRFMCO-SNAWJCMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURPIRINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Furanace"],"synonyms":["Nifurpirinol","P-7138"],"crossReferences":{"drugbank":["DB11436"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105864","canonicalSmiles":"COc1ccc(C[C@@H](CN[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2cccs2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCN=C(N)N)cc1","inchiKey":"IDXCXSCCZNCXCL-XMADEQCMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LABRADIMIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Labradimil","Lobradimil","RMP-7"],"crossReferences":{"drugbank":["DB06549"]},"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["EFO_0007228","EFO_0000326","EFO_0002939","EFO_1000158"],"count":4},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2105950","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"BYHDFCISJXIVBV-YWUHCJSESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOXICILLIN SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1082","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amoxicillin sodium","Amoxicillin sodium salt","Amoxycillin (as sodium)","BRL-2333AB-B","Sodium amoxicillin"],"crossReferences":{"chEBI":["51255"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for infection and pneumonia."}
{"id":"CHEMBL2106537","canonicalSmiles":"Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1","inchiKey":"DOTIMEKVTCOGED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIPRAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-16923","Mepiprazole"],"crossReferences":{"drugbank":["DB09197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107355","canonicalSmiles":"Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"ZJIHMALTJRDNQI-OLALXQGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGALASTAT HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL110458","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galafold"],"synonyms":["AT-1001 (MIGALASTAT HYDROCHLORIDE)","Migalastat hcl","Migalastat hydrochloride"],"crossReferences":{"DailyMed":["migalastat%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000102393"],"count":1},"linkedDiseases":{"rows":["Orphanet_324"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for fabry disease."}
{"id":"CHEMBL2107793","canonicalSmiles":"CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-XMSQKQJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHACETYLMETHADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-d-acetylmethadol","ACSCN-9603","Alphacemethadone","Alphacetylmethadol","IDS-NA-008"],"crossReferences":{"drugbank":["DB01555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107877","drugType":"Protein","blackBoxWarning":false,"name":"BLISIBIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-623","AMG 623","AMG-623","Blisibimod"],"linkedTargets":{"rows":["ENSG00000102524"],"count":1},"linkedDiseases":{"rows":["EFO_0007160","EFO_0002690","EFO_0005297","EFO_0004194","EFO_1000784"],"count":5},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108025","drugType":"Protein","blackBoxWarning":false,"name":"DEPELESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DX-890","Depelestat"],"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108045","drugType":"Antibody","blackBoxWarning":false,"name":"PRITUMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pritumumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108110","drugType":"Unknown","blackBoxWarning":false,"name":"THROMBIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thrombostat"],"synonyms":["Human thrombin","Thrombin","Thrombin (human)","Thrombin bovine","Thrombin human","Thrombin human plasma-derived","Thrombin topical human","Thrombin, topical (human)"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 10 investigational indications."}
{"id":"CHEMBL2108287","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"APRINOCARSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aprinocarsen","LY-900003","LY900003","Ly900003","Pkc-alpha"],"linkedTargets":{"rows":["ENSG00000154229"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108305","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN TREGOPIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IN-105","Insulin tregopil"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108545","drugType":"Unknown","blackBoxWarning":false,"name":"ORGOTEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ontosein","Orgotein","Orgotein, bovine","Ormetein","Palosein","Sod","Superoxide dismutase","Superoxide dismutase (bovine)"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108572","drugType":"Protein","blackBoxWarning":false,"name":"BALUGRASTIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balugrastim","CG-10639","CG10639"],"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108698","drugType":"Unknown","blackBoxWarning":false,"name":"WITCH HAZEL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demada lotio derm","Dickinson's witch hazel formula","Witch doctor","Witch hazel","Witch stik","Witch sun"],"synonyms":["American witchhazel leaf","American witchhazel twig water","American witchhazel whole","Hamamelidis folium","Hamamelis","Hamamelis leaf","Hamamelis macrophylla leaf","Hamamelis macrophylla twig water","Hamamelis virginiana l. leaf","Hamamelis virginiana leaf","Hamamelis virginiana twig water","Hamamelis virginiana whole","Witch hazel","Witch hazel leaf","Witch hazel twig water","Witch hazel whole","Witch-hazel leaf","Witch-hazel twig water","Witch-hazel whole","Witchhazel twig water","Witchhazel whole"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL2109067","drugType":"Enzyme","blackBoxWarning":false,"name":"KALLIDINOGENASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Padutin"],"synonyms":["Carnaculin","Glandular kallikrein porcine","Hog pancreas kallikrein","Kallidinogenase","Kallidinogenase (human urine)","Kallikrein, pancreatic porcine"],"description":"Enzyme drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2109211","drugType":"Unknown","blackBoxWarning":false,"name":"MEASLES VIRUS VACCINE LIVE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Attenuvax"],"synonyms":["Measles vaccine (live)","Measles virus live antigen","Measles virus live antigen, a","Measles virus vaccine live","Measles virus vaccine, live","Measles, live attenuated","Measles-k"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109224","drugType":"Antibody","blackBoxWarning":false,"name":"ROVELIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Leukarrest"],"synonyms":["HU-23F2G","HU23F2G","Rovelizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109286","drugType":"Antibody","blackBoxWarning":false,"name":"COLTUXIMAB RAVTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coltuximab ravtansine","SAR-3419","SAR3419"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000220","EFO_0000403","EFO_0005952"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109332","drugType":"Antibody","blackBoxWarning":false,"name":"MLNM-2201","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LDP-01","MLNM-2201"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109544","drugType":"Antibody","blackBoxWarning":false,"name":"CDP-860","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-860"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2111135","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)[N+](C)(C)C","inchiKey":"CDXCCYNINPIWGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAZINAMIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiazinam"],"crossReferences":{"drugbank":["DB13420"]},"childChemblIds":["CHEMBL2107499","CHEMBL2146061"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111152","canonicalSmiles":"CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"NMCHYWGKBADVMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENETHYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amfetyline","Amphetaminoethyltheophylline","Captagon","Fenethylline","Fenetylline","Fitton","HOMBURG-814","Phenethylline","Theophyllineethylamphetamine"],"crossReferences":{"drugbank":["DB01482"]},"childChemblIds":["CHEMBL2107591"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL22108","canonicalSmiles":"CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1","inchiKey":"MVMQESMQSYOVGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHINDENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dimethpyrindene","Dimetindene","Feniallerg","Forhistal"],"crossReferences":{"Wikipedia":["Dimetindene"],"drugbank":["DB08801"]},"childChemblIds":["CHEMBL1870768"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0004269","MONDO_0005271"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pruritus and allergic disease and has 1 investigational indication."}
{"id":"CHEMBL23327","canonicalSmiles":"CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1","inchiKey":"PMXCMJLOPOFPBT-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PURVALANOLA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piceatannol","Purvalanol A","Purvalanola"],"crossReferences":{"PubChem":["11111629","11114140"],"drugbank":["DB04751"],"chEBI":["47600"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL238071","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"HHJUWIANJFBDHT-ZVTSDNJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINDESINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["COMPOUND 112531","COMPOUND-112531","Vindesine"],"crossReferences":{"drugbank":["DB00309"]},"childChemblIds":["CHEMBL3989543"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 15 investigational indications."}
{"id":"CHEMBL24","canonicalSmiles":"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1","inchiKey":"METKIMKYRPQLGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ATENOLOL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antipressan","Atenamin","Atenix-100","Atenix-25","Atenix-50","Atenolol","Ibinolo","Kentol","Tenormin","Tenormin 25","Tenormin l.s.","Totamol","Unibloc","Vasaten"],"synonyms":["Atenolol","Atenololum","Betacard","C07AB03","Corotenol","Duraatenolol","Esatenolol","ICI 66,082","ICI 66082","ICI-66082","Juvental","Myocord","NSC-757832","Novaten","Prenormine","Urosin"],"crossReferences":{"DailyMed":["atenolol"],"PubChem":["144212743","26751696","50085956","50104387","855957","90340978"],"Wikipedia":["Atenolol"],"drugbank":["DB00335"],"chEBI":["2904"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0007372","EFO_0004214","EFO_0003777","EFO_0000275","EFO_0005323","EFO_0000401","EFO_0001358","EFO_0000319","Orphanet_558","EFO_0003882","EFO_0000537","EFO_0003913","EFO_0003914","EFO_0003896","MONDO_0001134","EFO_1001375","MONDO_0021661","EFO_0003144","EFO_0000712","EFO_0000612","EFO_0003763","EFO_0000400","EFO_1000635","EFO_0005251"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 7 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL24778","canonicalSmiles":"C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F","inchiKey":"PNCPYILNMDWPEY-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILODOSIN","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapaflo"],"synonyms":["KAD-3213","KMD-3213","Kso-0400","Rapilif","Silodal","Silodosin","Silodyx","Urief","Urorec"],"crossReferences":{"DailyMed":["silodosin"],"Wikipedia":["Silodosin"],"drugbank":["DB06207"]},"linkedTargets":{"rows":["ENSG00000120907"],"count":1},"linkedDiseases":{"rows":["EFO_0004253","EFO_1001228","EFO_0000284","EFO_0003830","HP_0000011","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for benign prostatic hyperplasia and has 3 investigational indications."}
{"id":"CHEMBL260933","canonicalSmiles":"CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O","inchiKey":"KOYXXLLNCXWUNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS 6201","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVT-6883","GS-6201","Gs 6201"],"crossReferences":{"PubChem":["103905523","174007167"],"drugbank":["DB05936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282146","canonicalSmiles":"CC(C)C[C@H](CC(=O)O)C(=O)N[C@H]1Cc2cn(c3ccccc23)CCCCCCNC1=O","inchiKey":"AKWKBACKRMYPRV-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL282146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3115681","canonicalSmiles":"CN1CCN(c2ccc(Nc3ncc4cc(C#N)c(=O)n(C5CCCC5)c4n3)cc2)CC1","inchiKey":"VADOZMZXXRBXNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ON123300","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["On123300"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3186011","canonicalSmiles":"COCC1(CO)C(=O)C2CCN1CC2","inchiKey":"BGBNULCRKBVAKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPRENETAPOPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APR-246","Apr 246","Apr-246","Eprenetapopt","PRIMA-1Met"],"crossReferences":{"PubChem":["174007096"],"drugbank":["DB11684"]},"linkedTargets":{"rows":["ENSG00000141510"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002916","EFO_0000756","MONDO_0008170","EFO_0002427","EFO_1001469"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL325041","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O","inchiKey":"GXJABQQUPOEUTA-RDJZCZTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BORTEZOMIB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Velcade"],"synonyms":["Bortezomib","Bortezomib accord","Bortezomib hydrate","LDP-341","NSC-681239","PS-341","Velcade"],"crossReferences":{"DailyMed":["bortezomib"],"PubChem":["124950705","144206183","144206225","170465087","518755"],"Wikipedia":["Bortezomib"],"drugbank":["DB00188"],"chEBI":["52717"]},"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_0004708","EFO_0000756","EFO_0000681","EFO_0005952","EFO_1001052","MONDO_0018896","EFO_0000308","Orphanet_85443","EFO_1001951","EFO_0000588","EFO_0000096","EFO_0000339","MONDO_0002974","MONDO_0008903","EFO_0003884","EFO_0000641","MONDO_0015277","EFO_0000198","MONDO_0013730","EFO_0002618","MONDO_0019465","EFO_0001642","EFO_1001968","EFO_1001946","MONDO_0004986","MONDO_0008627","MONDO_0008315","EFO_0001663","MONDO_0019139","EFO_1001365","EFO_0003032","EFO_0000574","EFO_0004256","EFO_0001378","Orphanet_207073","MONDO_0015564","EFO_1000550","EFO_0003073","EFO_0007183","MONDO_0003175","EFO_1001465","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0000326","EFO_0002499","EFO_0000183","EFO_0000707","EFO_0000616","EFO_0006859","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_1001875","MONDO_0007576","EFO_0004599","EFO_1001961","Orphanet_238510","EFO_0002517","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_0000519","MONDO_0000873","EFO_0000571","MONDO_0000956","EFO_0002426","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","Orphanet_365","MONDO_0019460","EFO_0000182","EFO_0000501","EFO_0007332","EFO_0000094","EFO_1000785","EFO_0009441","EFO_0000220","MONDO_0008170","MONDO_0044881","EFO_0000224","EFO_0002428","EFO_1001051","Orphanet_314701","MONDO_0009348","MONDO_0019471","MONDO_0015686","MONDO_0004192","EFO_1001469","EFO_0000209","MONDO_0002087","EFO_0000305","EFO_0000231","MONDO_0001187","EFO_0000673","EFO_1000158","EFO_0002501","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0006738","EFO_0000211","MONDO_0001705","EFO_0000095","EFO_0006475","EFO_1001226","EFO_0000191","EFO_1001936","EFO_0000691","EFO_0003811"],"count":117},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 4 approved and 97 investigational indications."}
{"id":"CHEMBL3301582","drugType":"Antibody","blackBoxWarning":false,"name":"POLATUZUMAB VEDOTIN","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Polivy"],"synonyms":["ACD-79B-VCMMAE","ACD-79BVCMMAE","ACD79B-VCMMAE","Anti-cd79b adc","DCDS-4501A","DCDS4501A","FCU-2711","FCU2711","Polatuzumab vedotin","Polatuzumab vedotin-piiq","RG-7596","RG7596","RO-5541077-000","RO-5541077000","RO5541077-000"],"crossReferences":{"DailyMed":["polatuzumab%20vedotin-piiq"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000007312","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0044889","EFO_0000096","EFO_0000095","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_1001469","EFO_0005952"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for neoplasm and diffuse large b-cell lymphoma and has 6 investigational indications."}
{"id":"CHEMBL3301605","canonicalSmiles":"O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O","inchiKey":"TWFRCSHLWKJBQH-UXQCFNEQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELEBACTAM","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3112741","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-relebactam monohydrate","MK-7655","MK-7655 MONOHYDRATE","Relebactam","Relebactam hydrate","Relebactam monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL3544911","canonicalSmiles":"COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1","inchiKey":"DOTGPNHGTYJDEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREXASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2606368","Prexasertib"],"crossReferences":{"drugbank":["DB12008"]},"linkedTargets":{"rows":["ENSG00000183765","ENSG00000149554"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001779","MONDO_0008170","EFO_0002939","EFO_0000222","EFO_0000708","EFO_0003060","EFO_0000311","EFO_0009708","EFO_0004284","EFO_0004142","EFO_0000702","MONDO_0001657","EFO_1000158"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL3544956","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrotinib","SHR-1258"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0003869","EFO_0000339","EFO_0008549","EFO_0005537","MONDO_0007254","EFO_0003060","EFO_1001951"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3545080","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7256","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-3603","Rg-7256","Ro-5212054"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545292","drugType":"Small molecule","blackBoxWarning":false,"name":"QBW251","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Qbw251"],"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545344","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05212377","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05212377","PF-5212377","Pf-05212377","SAM-760","WYE-103760"],"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707335","canonicalSmiles":"CC(=O)CC(=O)[O-].CC(=O)CC(=O)[O-].CC(=O)CC(=O)[O-].[Al+3]","inchiKey":"DEVXQDKRGJCZMV-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINIUM ACETOACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1230762","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aluminium acetoacetate"],"crossReferences":{"DrugCentral":["4761"],"drugbank":["DB13280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707348","canonicalSmiles":"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12","inchiKey":"WDENQIQQYWYTPO-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACALABRUTINIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calquence"],"synonyms":["ACP-196","Acalabrutinib","Acp-196"],"crossReferences":{"DailyMed":["acalabrutinib"],"drugbank":["DB11703"]},"childChemblIds":["CHEMBL4594293"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["MONDO_0044887","MONDO_0005271","EFO_1001469","EFO_0005952","EFO_0000565","EFO_0000096","MONDO_0019088","MONDO_0004695","MONDO_0002083","EFO_0009441","EFO_0002618","MONDO_0013730","EFO_0000685","MONDO_0008170","EFO_0000403","EFO_1000157","MONDO_0044881","EFO_0003060","EFO_0000311","EFO_0005741","MONDO_0100096","MONDO_0044889","MONDO_0001023","EFO_0000095","EFO_0000574","EFO_1001890","EFO_0001378","MONDO_0018906","EFO_0000519","EFO_0000181"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for mantle cell lymphoma and chronic lymphocytic leukemia and has 20 investigational indications."}
{"id":"CHEMBL376388","canonicalSmiles":"CNCc1ccc(-c2ncnc3[nH]cnc23)cc1","inchiKey":"VRGSDHJXBVCQEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376388","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07854"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833404","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)O.CC(=O)Oc1ccccc1C(=O)O.NC(N)=O","inchiKey":"QABKVYJFABZYAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBASPIRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbasalate"],"childChemblIds":["CHEMBL3833325"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989408","canonicalSmiles":"CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]","inchiKey":"VTGPMVCGAVZLQI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUPROFEN SODIUM","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL521","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Advil","Ibuprofen sodium"],"synonyms":["Ibuprofen sodium","Ibuprofen sodium dihydrate","Sodium ibuprofen dihydrate"],"crossReferences":{"DailyMed":["ibuprofen%20sodium"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1001139","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 2 investigational indications."}
{"id":"CHEMBL3989927","canonicalSmiles":"O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1","inchiKey":"IXZOHGPZAQLIBH-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBERDOMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-220","Iberdomide"],"crossReferences":{"drugbank":["DB12101"]},"childChemblIds":["CHEMBL3989912"],"linkedTargets":{"rows":["ENSG00000139842","ENSG00000113851","ENSG00000167986","ENSG00000100387"],"count":4},"linkedDiseases":{"rows":["Orphanet_797","HP_0000083","EFO_0003073","EFO_0002690","EFO_0001421","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_0001378","EFO_0005952"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3989937","canonicalSmiles":"CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F.Cl.Cl.O","inchiKey":"COWBUPJEEDYWKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPMATINIB HYDROCHLORIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3188267","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tabrecta"],"synonyms":["Capmatinib hydrochloride","Capmatinib hydrochloride hydrate","NVP-INC280-AAA"],"crossReferences":{"DailyMed":["capmatinib%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL4129286","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@@]1(F)O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(O)[C@@H]1O)Oc1ccccc1","inchiKey":"NIJYGVDQZBBONK-SEUXLIJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADAFOSBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-335","Adafosbuvir","Al-335","JNJ-335"],"crossReferences":{"drugbank":["DB14906"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4225088","canonicalSmiles":"CCc1ccc(N(CC(C)C)S(=O)(=O)c2ccc(OCC3CCOCC3)c(CO)c2)cc1","inchiKey":"LZLBRISQTJVZNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2981278","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK2981278","Gsk-2981278","Gsk2981278","Ror gama modulator 1"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297214","canonicalSmiles":"OC(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)(C(F)(F)F)C(F)(F)F","inchiKey":"CYSJNTQNMDWAJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALICIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IW-1973","Praliciguat"],"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["EFO_0003144"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297286","canonicalSmiles":"C[C@@H]1CN(c2ccc(F)cc2C(F)(F)F)CCN1S(=O)(=O)c1cccc([C@@](C)(O)C(F)(F)F)c1","inchiKey":"ZWASRJHIEFYJGL-BFUOFWGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HSD-016","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hsd-016"],"crossReferences":{"drugbank":["DB12419"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297376","canonicalSmiles":"Cc1ccc(NS(=O)(=O)c2cccc(C#N)c2)c2[nH]cc(C#N)c12","inchiKey":"LWGUASZLXHYWIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7820","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7820","E7820","ER-68203-00"],"crossReferences":{"drugbank":["DB12505"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297421","canonicalSmiles":"O=C(Nc1nc(-c2ccc(O)c(O)c2)c(-c2ccccc2)s1)c1ccc(O)c(O)c1","inchiKey":"LGGDLPSXAGQFSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COH-29","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COH29","Coh-29","Rnr inhibitor coh29"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297458","canonicalSmiles":"Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1","inchiKey":"KGERZPVQIRYWRK-GDLZYMKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986158","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986158","Bet inhibitor bms-986158","Bms-986158"],"crossReferences":{"drugbank":["DB15435"]},"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0044903","EFO_0000574"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297512","canonicalSmiles":"O=C[C@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"BYZQBCIYLALLPA-NOPGXMAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAXILOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gaxilose"],"crossReferences":{"drugbank":["DB12767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297702","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-936559","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-pdl-1 antibody bms-936559","Bms-936559","MDX-1105","MDX1105"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297778","drugType":"Antibody","blackBoxWarning":false,"name":"LONCASTUXIMAB TESIRINE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zynlonta"],"synonyms":["ADCT-402","ADCT-402 TESIRINE","Adct-402 tesirine","Loncastuximab tesirine","Loncastuximab tesirine-lpyl"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000309","EFO_0000096","EFO_0000220","EFO_0000403","MONDO_0018906","EFO_1001938","EFO_1001469","EFO_0005952"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for diffuse large b-cell lymphoma and b-cell non-hodgkins lymphoma and has 3 investigational indications."}
{"id":"CHEMBL4297825","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SEVUPARIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DF-02","DF02","Sevuparin"],"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298055","drugType":"Protein","blackBoxWarning":false,"name":"ALDAFERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aldafermin","NGM-282","NGM282","Ngm282"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4298082","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recombinant nematode anticoagulant protein c2","Recombinant nematode anticoagulant protein c2 (rnapc2)","Rnapc2"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298104","drugType":"Unknown","blackBoxWarning":false,"name":"CBS-9106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CBS-9106","Cbs-9106","Felezonexor","S-03747","SL-801","Sl-801"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL430","canonicalSmiles":"CO/N=C1\\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN","inchiKey":"ZRCVYEYHRGVLOC-HYARGMPZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GEMIFLOXACIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Factiv","Gemifloxacin"],"crossReferences":{"DailyMed":["gemifloxacin%20mesylate"],"Wikipedia":["Gemifloxacin"],"drugbank":["DB01155"],"chEBI":["101853"]},"childChemblIds":["CHEMBL1200621"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for bacterial disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4302512","drugType":"Small molecule","blackBoxWarning":false,"name":"THALLOUS CHLORIDE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-15197","Thallium chloride (tlcl)"],"crossReferences":{"DailyMed":["thallous%20chloride%20tl-201"]},"childChemblIds":["CHEMBL1200535"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for myocardial infarction and coronary artery disease."}
{"id":"CHEMBL4303241","canonicalSmiles":"COc1cc(S(C)(=O)=O)ccc1Nc1nc2ccc(-c3ccc(NC(=O)[C@H](C)c4ccc(F)cc4)cc3)cn2n1","inchiKey":"NRJKIOCCERLIDG-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1161909","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-BAY-1161909","BAY 1161909","Bay-1161909","Empesertib","MPS1-IN-5"],"linkedTargets":{"rows":["ENSG00000112742"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL436774","canonicalSmiles":"CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1","inchiKey":"HUDQLWBKJOMXSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR9281","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ar9281"],"crossReferences":{"drugbank":["DB06345"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL441765","canonicalSmiles":"CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@@H]1CCCC[C@H]1N1CCCC1","inchiKey":"VQLPLYSROCPWFF-QZTJIDSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"U-50488 METHANE SULFONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["U-50488"],"crossReferences":{"PubChem":["11111942","11111943","26756547"],"Wikipedia":["U-50488"],"chEBI":["73358"]},"childChemblIds":["CHEMBL1256834","CHEMBL482811","CHEMBL1793845","CHEMBL2062342"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL445","canonicalSmiles":"CNCCC=C1c2ccccc2CCc2ccccc21","inchiKey":"PHVGLTMQBUFIQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORTRIPTYLINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allegron","Aventyl","Motipress","Motival"],"synonyms":["Desitriptilina","Lumbeck","NCI-169453","NSC-757234","Noramitriptyline","Nortrilen","Nortriptyline","Pamelor","Sesaval"],"crossReferences":{"DailyMed":["nortriptyline%20hydrochloride"],"PubChem":["11110653","11110654","124878449","152146160","26747092","26747093","4253930","50100156","50104257","50104258","90340759"],"Wikipedia":["Nortriptyline"],"drugbank":["DB00540"],"chEBI":["7640"]},"childChemblIds":["CHEMBL1201156"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","HP_0000360","MONDO_0002009","EFO_0000555","HP_0000726","EFO_0003768","EFO_1002014","EFO_0000274","EFO_1000948","EFO_0008533","EFO_0003948","EFO_0009562","EFO_0000289","MONDO_0002050","EFO_0011023","EFO_0008524","EFO_0000676","EFO_0009854","EFO_0003761","EFO_0005279","EFO_0005230"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for unipolar depression and depressive disorder and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL449158","canonicalSmiles":"CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3","inchiKey":"MJQUEDHRCUIRLF-TVIXENOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRYOSTATIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bryostatin","Bryostatin 1"],"crossReferences":{"PubChem":["144206307"],"chEBI":["88353"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 25 investigational indications."}
{"id":"CHEMBL4594461","drugType":"Unknown","blackBoxWarning":false,"name":"AUTOLOGOUS CORD BLOOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Autologous cord blood","Autologous human umbilical cord blood","Autologous umbilical cord blood"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL4594518","drugType":"Antibody","blackBoxWarning":false,"name":"LUTIKIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-1234138","ABT-981","Abt-981","Lutikizumab"],"linkedTargets":{"rows":["ENSG00000115008","ENSG00000125538"],"count":2},"linkedDiseases":{"rows":["EFO_1000710","EFO_1000789","MONDO_0005178"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594600","drugType":"Unknown","blackBoxWarning":false,"name":"HUMAN NEUREGULIN-1 RECOMBINANT (177-237)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human neuregulin-1 recombinant (177-237)","Neucardin","Rhnrg-1"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460291","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C","inchiKey":"GKQPCPXONLDCMU-CCEZHUSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACIDIPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Caldine","Molap","Motens"],"synonyms":["3,3'-iminobispropylamine","3,3'-iminodipropylamine","4-azaheptamethylenediamine","Dipropylamine, 3,3'-diamino-","Dipropylenetriamine","GR 43659X","GR-43659X","Lacidipine","NSC-7773"],"crossReferences":{"PubChem":["144205727","170465580"],"drugbank":["DB09236"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL464345","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E574"],"crossReferences":{"PubChem":["144209943"],"Wikipedia":["Gluconic_acid"],"drugbank":["DB13180"],"chEBI":["33198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650248","drugType":"Antibody","blackBoxWarning":false,"name":"CASIRIVIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Casirivimab","REGN-10933","REGN10933"],"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650348","canonicalSmiles":"NC(=O)N(C(=O)c1ccccc1)c1ccccc1","inchiKey":"XYFMGGWVGACNEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOYLPHENYLUREA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzoylphenylurea"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650373","drugType":"Unknown","blackBoxWarning":false,"name":"APELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apelin"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL477508","canonicalSmiles":"O=c1[nH]c(=O)c2c([nH]1)n(C[C@H](O)[C@H](O)[C@H](O)CO)c(=O)n2CCCOP(=O)(O)O","inchiKey":"KPHFGOGGKPGLTM-OOZYFLPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL477508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483465","canonicalSmiles":"Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3","inchiKey":"FARXPFGGGGLENU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-ING-41","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-ING-41","9-ing-41","Elraglusib"],"linkedTargets":{"rows":["ENSG00000082701"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000044","MONDO_0044903","MONDO_0100342","MONDO_0021117","EFO_1000350","MONDO_0002367","EFO_0000691","EFO_0009708"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL501259","canonicalSmiles":"CCCCCC/C=C\\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)(O)O)[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)(O)O)[C@@H]1OCC[C@@H](CCCCCCC)OC","inchiKey":"BPSMYQFMCXXNPC-MFCPCZTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERITORAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E5564","Eritoran"],"crossReferences":{"Wikipedia":["Eritoran"],"drugbank":["DB04933"],"chEBI":["68609"]},"childChemblIds":["CHEMBL3301672"],"linkedTargets":{"rows":["ENSG00000154589","ENSG00000136869"],"count":2},"linkedDiseases":{"rows":["EFO_0003106","EFO_0000565","HP_0100806","MONDO_0100096","EFO_0002614","EFO_0007328"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL528988","canonicalSmiles":"CCCCOc1ccc2cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc2c1","inchiKey":"UAGYXJBYAFGRFR-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL528988","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL541253","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"JOXIMZWYDAKGHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-Toluenesulfonate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-Toluenesulfonate"],"crossReferences":{"PubChem":["144209562"],"Wikipedia":["P-Toluenesulfonic_acid"],"drugbank":["DB03120"],"chEBI":["27849"]},"childChemblIds":["CHEMBL3183883"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561360","canonicalSmiles":"CC(C)N(c1cc(-c2ccccc2)sc1C(=O)O)C(=O)[C@H]1CC[C@H](C)CC1","inchiKey":"RZXQBIKGWSLVEK-JCNLHEQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08279"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL615","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"BPLBGHOLXOTWMN-MBNYWOFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN V","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["V-cillin"],"synonyms":["Distaquaine v","Penapar-VK","Penicillin phenoxymethyl","Penicillin v","Penicillin-VK","Phenomycilline","Phenoxymethylpenicillin","Phenoxymethylpenicillinum","Vebecillin","Veetids"],"crossReferences":{"DailyMed":["penicillin%20v%20potassium"],"PubChem":["29215255"],"Wikipedia":["Phenoxymethylpenicillin"],"drugbank":["DB00417"],"chEBI":["27446"]},"childChemblIds":["CHEMBL1396177","CHEMBL2103963","CHEMBL1200852"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and has 7 approved and 3 investigational indications."}
{"id":"CHEMBL70421","canonicalSmiles":"CC(C)[C@@H](NC(=O)[C@H](CS)NC(=O)CCC[C@H](N)C(=O)O)C(=O)O","inchiKey":"BYEIJZFKOAXBBV-ATZCPNFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL70421","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02025"],"chEBI":["28496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL82202","canonicalSmiles":"Cc1ncc(COP(=O)(O)O)c(C=O)c1O","inchiKey":"NGVDGCNFYWLIFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAL PHOSPHATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridoxal Phosphate","Pyridoxal phosphate"],"crossReferences":{"PubChem":["29218058"],"Wikipedia":["Pyridoxal_phosphate"],"drugbank":["DB00114"],"chEBI":["18405"]},"childChemblIds":["CHEMBL3989490","CHEMBL3181870"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL893","canonicalSmiles":"Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"YFAGHNZHGGCZAX-JKIFEVAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLOXACILLIN","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL-1702","Dicloxacillin","Dycill","Dynapen","Pathocil","R-13423"],"crossReferences":{"DailyMed":["dicloxacillin%20sodium"],"PubChem":["124893598"],"Wikipedia":["Dicloxacillin"],"drugbank":["DB00485"],"chEBI":["4511"]},"childChemblIds":["CHEMBL1200701","CHEMBL26570"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for infection and bacterial disease and has 3 investigational indications."}
{"id":"CHEMBL898","canonicalSmiles":"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O","inchiKey":"HUPFGZXOMWLGNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIFLUNISAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diflunisal","Dolobid","Dolobid 500"],"synonyms":["Diflunisal","NSC-756728"],"crossReferences":{"DailyMed":["diflunisal"],"PubChem":["11112675","124882514","144204149","170464956","26746997","855794"],"Wikipedia":["Diflunisal"],"drugbank":["DB00861"],"chEBI":["39669"]},"childChemblIds":["CHEMBL4745456"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","HP_0001945","EFO_0000764","MONDO_0005148","MONDO_0005178","EFO_0003843","Orphanet_85447"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL90488","canonicalSmiles":"CN(C)S(=O)(=O)N1CCN(c2ccnc(CO)n2)CC1","inchiKey":"XDTHNROWHAAVPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-166572","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-166572"],"crossReferences":{"drugbank":["DB04478"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93298","canonicalSmiles":"CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1","inchiKey":"BHIAIPWSVYSKJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AROTINOLOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arotinolol","Arotinolol hydrochloride","NSC-317940"],"crossReferences":{"Wikipedia":["Arotinolol"],"drugbank":["DB09204"]},"childChemblIds":["CHEMBL3185966"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL946","canonicalSmiles":"CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1","inchiKey":"SEBMTIQKRHYNIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZATADINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Azatadine","Optimine","Trinalin"],"crossReferences":{"PubChem":["144206535","170464865"],"Wikipedia":["Azatadine"],"drugbank":["DB00719"],"chEBI":["2946"]},"childChemblIds":["CHEMBL3544908"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977 and is indicated for allergic disease."}
{"id":"CHEMBL993","canonicalSmiles":"Cc1c[nH]c(=O)[nH]c1=O","inchiKey":"RWQNBRDOKXIBIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thymine"],"crossReferences":{"Wikipedia":["Thymine"],"drugbank":["DB03462"],"chEBI":["17821"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
